Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer
- Sponsor
- University Hospital Schleswig-Holstein
- Study ID
- NCT07627022
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- mobile application (reminder app) — DEVICEMobile application (reminder app) that reminds patients three to four times daily to walk a pre-defined number of steps.
- Standard radiotherapy — RADIATIONPatients receive standard radiotherapy or radio-chemotherapy for lung cancer.
Study Details
The primary objective of this prospective randomized trial is to explore whether the use of a smart phone-based reminder application is associated with a change in physical activity during radiation therapy in patients with lung cancer. The primary endpoint focuses on the within-patient change in physical activity between Week 1 and Week 5, with comparison between treatment groups to assess potential differences attributable to the intervention. Secondary objectives include the exploratory assessment of patient satisfaction with the reminder app, its impact on the use and perception of digital health technology. A total of 28 evaluable patients in the Full Analysis Set (approximately 14 per treatment arm) are required to detect a clinically relevant difference corresponding to a probability of superiority of approximately 0.65 with 80% power at a two-sided significance level of 0.05. Assuming that approximately 10% of patients will not be evaluable for the primary endpoint, a total of 32 patients will be randomized.
Key Dates
- First listed
- Jun 4, 2026
- Start date
- Jul 1, 2026
- Status verified
- May 2026
- Primary completion
- Feb 15, 2027
- Completion
- Feb 15, 2027
Study Design
- Enrollment
- 32 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Standard treatment supported by a reminder app (Arm A)The patients receive radiotherapy or radio-chemotherapy for locally advanced lung cancer. They will be reminded by an app three to four times a day to perform a pre-defined number of steps. The patients are asked at the end of each day to confirm whether or not they reached the required number of steps.
- Active Comparator: Standard treatment without a reminder app (Arm B)The patients receive radiotherapy or radio-chemotherapy for locally advanced lung cancer. They will not be reminded by an app to perform a pre-defined number of steps. The patients are asked at the end of each day to confirm whether or not they reached the required number of steps.
Primary Outcome Measure
Mean number of steps per week during week 1 and week 5 of radiation therapy for lung cancer [ Time Frame: through study completion, 5 weeks ]
Central Contacts
- Dirk Rades, Prof. Dr.0049-451-500
- Maria K Streubel, Dr. rer.nat.0049.451-500
Find similar trials
Related Studies
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Detection of Genetic Markers of Lung CancerRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Lung Cancer Biomarkers and ScreeningRecruiting · NYU Langone Health · New York, New York